Neutralizing antibody to Mengo virus, induced by synthetic peptides

References

1. Baron M. H., Baltimore D. 1982; Antibodies against the chemically synthesized genome-linked proteins of poliovirus react with native virus proteins. Cell 28:395–404
   [Google Scholar]
2. Bittle J. L., Houghten R. A., Alexander H., Shinnick T. M., Sutcliffe J. G., Lerner R. A. 1982; Protection against foot- and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence. Nature, London 293:30–33
   [Google Scholar]
3. Boege U., Scraba D. G. 1989; Mengo virus maturation is accompanied by C-terminal modification of capsid protein VP1. Virology 168:409–412
   [Google Scholar]
4. Boege U., Ko D. S. W., Scraba D. G. 1986; Toward an in vitro system for picomavirus assembly: purification of mengovirus 14S capsid precursor particles. Journal of Virology 57:275–284
   [Google Scholar]
5. Dick G. W. A. 1948; Mengoencephalomyelitis virus: pathogenicity for animals and physical properties. British Journal of Experimental Pathology 29:559–577
   [Google Scholar]
6. DiMarchi R., Brooke G., Gale C., Cracknell V., Doel T., Mowat N. 1986; Protection of cattle against foot-and-mouth disease by a synthetic peptide. Science 232:639–641
   [Google Scholar]
7. Doel T. R., Gale C., Brooke G., DiMarchi R. 1988; Immunization against foot-and-mouth disease with synthetic peptides representing the C-terminal region of VP1. Journal of General Virology 69:2403–2406
   [Google Scholar]
8. Ellem K. A. O., Colter J. S. 1961; The isolation of three variants of mengo virus differing in plaque morphology and hemagglutinat- ing characteristics. Virology 15:340–347
   [Google Scholar]
9. Francis M. J., Fry C. M., Rowlands D. J., Brown F., Bittle J. L., Houghten R. A., Lerner R. A. 1985; Priming with peptides of foot-and-mouth disease virus. In Vaccines’85: Molecular and Chemical Basis of Resistance to Parasitic, Bacterial and Viral Diseases pp 203–210 Edited by Lemer R. A, Chanock R. M., Brown F. New York: Cold Spring Harbor Laboratory;
   [Google Scholar]
10. Francis M. J., Fry C. M., Rowlands D. J., Bittle J. L., Houghten R. A., Lerner R. A., Brown F. 1987; Immune response to uncoupled peptides of foot-and-mouth disease virus. Immunology 61:1–6
    [Google Scholar]
11. Guthke R., Veckenstedt A., Guttner J., Stracke R., Bergter F. 1987; Dynamic model of the pathogenesis of mengo vims infection in mice. Acta virologica 31:307–320
    [Google Scholar]
12. Hagenmaier H., Frank H. 1972; Increased coupling yields in solid phase peptide synthesis with a modified carbodiimide coupling procedure. Hoppe-Seyler’s Zeitschrift für physiologische Chemie 353:(S)1973–1976
    [Google Scholar]
13. Houghten R. A. 1985; General method for the rapid solid-phase synthesis of large numbers of peptides: specificity of antigen- antibody interaction at the level of individual amino acids. Proceedings of the National Academy of Sciences, U.S.A 82:5131–5135
    [Google Scholar]
14. Lund G. A., Ziola B. R., Salmi A., Scraba D. G. 1977; Structure of the mengo virion. V. Distribution of the capsid polypeptides with respect to the surface of the virus particle. Virology 78:35–44
    [Google Scholar]
15. Luo M., Vriend G., Kramer G., Minor I., Arnold E., Rossmann M., Boege U., Scraba D., Duke G., Palmenberg A. 1987; The atomic resolution of mengo virus at 3.0Å resolution. Science 235:182–191
    [Google Scholar]
16. Meloen R. H., Barteling S. J. 1986; An epitope located at the C terminus of isolated VP1 of foot-and-mouth disease virus type O induces neutralizing activity but poor protection. Journal of General Virology 67:289–294
    [Google Scholar]
17. Meloen R. H., Puyk W. C., Posthumus W. P. A., Lankhof H., Thomas A., Schapper W. M. M. 1988; Use of peptides to locate and characterize epitopes. In Vaccines’88: Modern Approaches to New Vaccines pp 35–40 Edited by Lemer R. A., Chanock R. M., Brown F. New York: Cold Spring Harbor Laboratory;
    [Google Scholar]
18. Merrifield R. A. 1963; Solid phase peptide synthesis I. The synthesis of a tetrapeptide. Journal of the American Chemical Society 85:2149–2154
    [Google Scholar]
19. Muir S. J., Bittle J. L. 1989; Reactivity of mengovirus synthetic peptides containing the amino acid sequence of immunodominant antigenic sites. In Vaccines’89: Modern Approaches to New Vaccines Including Prevention of AIDS pp 457–461 Edited by Lemer R. A., Ginsberg H., Chanock R. M., Brown F. New York: Cold Spring Harbor Laboratory;
    [Google Scholar]
20. Ohara Y., Senkowski A., Fu J., Klaman L., Goodall J., Toth M., Roos R. 1988; Trypsin-sensitive neutralizing site on VP1 of Theiler’s murine encephalomyelitis viruses. Journal of Virology 62:3527–3529
    [Google Scholar]
21. Ouldridge E. J., Barnett P. V., Parry N. R., Syred A., Head M., Rweyemamu M. M. 1984; Demonstration of neutralizing and non-neutralizing epitopes on the trypsin-sensitive site of foot-and- mouth disease vims. Journal of General Virology 65:203–207
    [Google Scholar]
22. Parry N. R., Ouldridge E. J., Barnett P. V., Rowlands D. J., Brown F., Bittle J. L., Houghten R. A., Lerner R. A. 1985; Identification of neutralizing epitopes of foot-and-mouth disease vims. In Vaccines 85: Molecular and Chemical Basis for Parasitic, Bacterial and Viral Diseases pp 211–216 Edited by Lemer R. A., Chanock R. M., Brown F. New York: Cold Spring Harbor Laboratory;
    [Google Scholar]
23. Parry N. R., Ouldridge E. J., Barnett P. V., Clarke B. E., Francis M. J., Fox J. D., Rowlands D. J., Brown F. 1989; Serological prospects for peptide vaccines against foot-and-mouth disease virus. Journal of General Virology 70:2919–2930
    [Google Scholar]
24. Scraba D. G., Kay C. M., Colter J. S. 1967; Physicochemical studies of three variants of Mengo vims and their constituent ribonucleates. Journal of Molecular Biology 26:67–99
    [Google Scholar]
25. Stringfellow D. A., Overall J. C., Glasgow L. A. 1974; Interferon inducers in therapy of infection with encephalomyocardi- tis vims in mice. Journal of Infectious Diseases 130:470–480
    [Google Scholar]
26. Strohmaier K., Franze R., Adam K.-H. 1982; Location and characterization of the antigenic portion of the FMDV immunizing protein. Journal of General Virology 59:295–306
    [Google Scholar]
27. Thomas A. A. M., Woortmeijer R. J., Puijk W., Barteling S. J. 1988; Antigenic sites on foot-and-mouth disease virus type A10. Journal of Virology 62:2782–2789
    [Google Scholar]
28. Veckenstedt A. 1974; Pathogenicity of Mengo virus to mice. I. Virological studies. Acta virologica 18:501–507
    [Google Scholar]
29. Veckenstedt A., Horn M. 1974; Testing of antiviral compounds against Mengo vims infection of mice. Experimental Chemotherapy 20:235–244
    [Google Scholar]
30. Xie Q.-C., McCahon D., Crowther J. R., Belsham G. J., McCullough K. C. 1987; Neutralization of foot-and-mouth disease vims can be mediated through any of at least three separate antigenic sites. Journal of General Virology 681637–1647
    [Google Scholar]